P05.08 High-grade gliomas and immunotherapeutic early phase clinical trials: a single-center experience

BACKGROUND: Patients with high-grade gliomas (HGGs) have historically been excluded from immunotherapeutic early-phase clinical trials (ieCTs) due to unavailability of serial bioptic sampling, the frequent need of corticosteroids, concerns regarding activity of immunotherapy in central nervous syste...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Neuro Oncol
Main Authors: Simonelli, M, Persico, P, Dipasquale, A, Lorenzi, E, Giordano, L, Pessina, F, Navarria, P, Scorsetti, M, Bello, L, Santoro, A
Formato: Artigo
Idioma:Inglês
Publicado: Oxford University Press 2019
Assuntos:
Poster Presentations
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6796051/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noz126.122
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares